Cost Of HIV Drugs Cost Less Than Previously Thought, Clinton Foundation Study Says

“Lack of money can no longer be considered a reason — or an excuse — for failing to treat all those with HIV who need drugs to stay alive, following game-changing work about to be published by the Clinton Foundation that shows the real cost is four times less than previously thought,” the Guardian reports (Boseley, 7/20). A new study conducted by the Clinton Health Access Initiative (CHAI), in partnership with five African countries and the Center for Global Development, “provides new evidence that aggressive scale-up of high-quality treatment in developing countries is possible and sustainable,” according to a CHAI press release (7/20).

According to the Guardian “[t]he work by the Clinton Health Access Initiative (CHAI) shows that the total cost of treatment in health facilities — including drugs, lab tests, health workers’ salaries and other overheads — comes to an average of $200 a patient a year across Ethiopia, Malawi, Rwanda and Zambia — four of the … African nations studied” and “rises to $682 in South Africa, which has higher salaries and lab costs.” The news service notes, “Until now the generally accepted total cost of treating a patient for a year was an average of $880 — based on a study by [PEPFAR and] released at the last International AIDS Conference two years ago in Vienna” (7/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.